Literature DB >> 35771944

Molecular ZIP codes in targeted drug delivery.

Erkki Ruoslahti1,2.   

Abstract

The term "molecular ZIP (or area) codes" refers to an originally hypothetical system of cell adhesion molecules that would control cell trafficking in the body. Subsequent discovery of the integrins, cadherins, and other cell adhesion molecules confirmed this hypothesis. The recognition system encompassing integrins and their ligands came particularly close to fulfilling the original ZIP code hypothesis, as multiple integrins with closely related specificities mediate cell adhesion by binding to an RGD or related sequence in various extracellular matrix proteins. Diseased tissues have their own molecular addresses that, although not necessarily involved in cell trafficking, can be made use of in targeted drug delivery. This article discusses the molecular basis of ZIP codes and the extensive effort under way to harness them for drug delivery purposes.

Entities:  

Keywords:  bacteriophage; cancer drugs; integrins; neuropilin; tumor vessels

Mesh:

Substances:

Year:  2022        PMID: 35771944      PMCID: PMC9282239          DOI: 10.1073/pnas.2200183119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  108 in total

1.  An engineered 4-1BBL fusion protein with "activity on demand".

Authors:  Jacqueline Mock; Marco Stringhini; Alessandra Villa; Michael Weller; Tobias Weiss; Dario Neri
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-25       Impact factor: 11.205

2.  Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.

Authors:  Kazuki N Sugahara; Tambet Teesalu; Priya Prakash Karmali; Venkata Ramana Kotamraju; Lilach Agemy; Daniel R Greenwald; Erkki Ruoslahti
Journal:  Science       Date:  2010-04-08       Impact factor: 47.728

Review 3.  Vascular cell adhesion molecule-1 (VCAM-1)--an increasing insight into its role in tumorigenicity and metastasis.

Authors:  Martin Schlesinger; Gerd Bendas
Journal:  Int J Cancer       Date:  2014-05-06       Impact factor: 7.396

4.  Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression.

Authors:  Yanhong Guo; Wenmin Yuan; Bilian Yu; Rui Kuai; Wenting Hu; Emily E Morin; Minerva T Garcia-Barrio; Jifeng Zhang; James J Moon; Anna Schwendeman; Y Eugene Chen
Journal:  EBioMedicine       Date:  2017-12-20       Impact factor: 8.143

5.  Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics.

Authors:  Colin G Buss; Sangeeta N Bhatia
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-03       Impact factor: 11.205

Review 6.  Nanoparticle-Based Approaches towards the Treatment of Atherosclerosis.

Authors:  Artur Y Prilepskii; Nikita S Serov; Daniil V Kladko; Vladimir V Vinogradov
Journal:  Pharmaceutics       Date:  2020-11-05       Impact factor: 6.321

7.  Alternative Splicing of FN (Fibronectin) Regulates the Composition of the Arterial Wall Under Low Flow.

Authors:  Patrick A Murphy; Noor Jailkhani; Sarah-Anne Nicholas; Amanda M Del Rosario; Jeremy L Balsbaugh; Shahinoor Begum; Amy Kimble; Richard O Hynes
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-11-19       Impact factor: 8.311

8.  A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI.

Authors:  Furong Ye; Xueming Wu; Eun-Kee Jeong; Zhanjun Jia; Tianxin Yang; Denis Parker; Zheng-Rong Lu
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

9.  Tumor-penetrating peptides.

Authors:  Tambet Teesalu; Kazuki N Sugahara; Erkki Ruoslahti
Journal:  Front Oncol       Date:  2013-08-27       Impact factor: 6.244

10.  Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer.

Authors:  Daniel V T Catenacci; Melissa R Junttila; Theodore Karrison; Nathan Bahary; Margit N Horiba; Sreenivasa R Nattam; Robert Marsh; James Wallace; Mark Kozloff; Lakshmi Rajdev; Deirdre Cohen; James Wade; Bethany Sleckman; Heinz-Josef Lenz; Patrick Stiff; Pankaj Kumar; Peng Xu; Les Henderson; Naoko Takebe; Ravi Salgia; Xi Wang; Walter M Stadler; Frederic J de Sauvage; Hedy L Kindler
Journal:  J Clin Oncol       Date:  2015-11-02       Impact factor: 44.544

View more
  1 in total

1.  Richard Hynes, Erkki Ruoslahti, and Timothy Springer receive Lasker prize for pioneering work on integrins.

Authors:  Hidayatullah G Munshi
Journal:  J Clin Invest       Date:  2022-09-28       Impact factor: 19.456

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.